Macroview Investment Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Macroview Investment Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24	Closed	-$16	–	657
2024 Q2	$16	Hold	24	–	–	﹤0.01%	584
2024 Q1	$15	Hold	24	–	–	﹤0.01%	632
2023 Q4	$15	Hold	24	–	–	﹤0.01%	620
2023 Q3	$16	Hold	24	–	–	﹤0.01%	796
2023 Q2	$79	Sell	24 -1	-4%	-$3	﹤0.01%	488
2023 Q1	$224	Hold	25	–	–	﹤0.01%	432
2022 Q4	$288	Hold	25	–	–	﹤0.01%	434
2022 Q3	$1K	Hold	25	–	–	﹤0.01%	399
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	431
2022 Q1	$1K	Hold	25	–	–	﹤0.01%	417
2021 Q4	$2K	Hold	25	–	–	﹤0.01%	338
2021 Q3	$2K	Hold	25	–	–	﹤0.01%	331
2021 Q2	$2K	Hold	25	–	–	﹤0.01%	357
2021 Q1	$2K	Buy	+25	New	+$2.54K	﹤0.01%	331

Macroview Investment Management's VBIV Position: Q3 2024 in Review

Macroview Investment Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2024, closing a stake of 24 shares — an estimated $16 sold.

Macroview Investment Management first reported a position in VBIV in Q1 2021 and held it in 14 quarters. The position peaked at $2K in Q4 2021. 1 fund tracked by Wall St. Rank holds VBIV as of Q3 2024.

Macroview Investment Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2024 after selling out during the quarter.
Macroview Investment Management sold 24 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2024, an estimated $16.
Macroview Investment Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2021 and held it in 14 quarters.
Macroview Investment Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2K in Q4 2021.
1 fund tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2024.

Based on Macroview Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.